Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial"

J Clin Endocrinol Metab. 2023 Jul 14;108(8):e644-e645. doi: 10.1210/clinem/dgad096.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Randomized Controlled Trial
  • Letter
  • Comment

MeSH terms

  • Child
  • Dwarfism, Pituitary* / drug therapy
  • Human Growth Hormone* / adverse effects
  • Humans

Substances

  • somapacitan
  • Human Growth Hormone